ArticleBlood cell therapy2021

Efficacy and safety of venetoclax in combination therapy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

Fan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.